Severe Anemia Management

Definition and Diagnosis

Severe anemia is defined as hemoglobin ≤10 g/dL, with the World Health Organization defining anemia as <12 g/dL in women and <13 g/dL in men 2
Hemoglobin levels below 7 g/dL represent critical anemia requiring urgent intervention 1

For a previously healthy adult with severe anemia, immediately transfuse 2-3 units of packed red blood cells targeting an initial hemoglobin of 7-8 g/dL, while simultaneously investigating the underlying cause 1
Transfuse 2-3 units of packed red blood cells immediately for critically low hemoglobin, with each unit expected to increase hemoglobin by approximately 1.5 g/dL 1
Target an initial hemoglobin of 7-8 g/dL for stabilization in most stable, non-cardiac patients 1
Use a restrictive transfusion threshold of <7.0 g/dL in hospitalized patients without active bleeding or cardiovascular symptoms 1
For patients with acute coronary syndrome or ischemic heart disease, consider a higher transfusion threshold of 8 g/dL, as restrictive transfusion in cardiovascular patients increases risk (RR: 1.78, 95% CI 1.18-2.70) 1, 3

Obtain reticulocyte count (>10 × 10⁹/L indicates regenerative anemia), lactate dehydrogenase, indirect bilirubin, and haptoglobin levels to assess for hemolysis 1
Perform complete blood count with differential to assess other cell lines 1
Check peripheral blood smear for schistocytes, malaria parasites, or morphologic abnormalities 1
Measure serum erythropoietin in all patients with severe anemia (Hb ≤10 g/dL) 4

For patients with hemoglobin ≤10 g/dL and serum erythropoietin ≤500 mU/dL, erythropoietic stimulating agents are recommended 4
Discontinue erythropoietin after 6-8 weeks if no response (less than 1-2 g/dL rise in hemoglobin), and investigate for tumor progression or iron deficiency 5
Target hemoglobin of 12 g/dL; insufficient evidence supports normalization above 12 g/dL 5

Avoid liberal transfusion strategies targeting hemoglobin >10 g/dL, as this increases transfusion requirements without improving outcomes 1
Do not continue erythropoietin beyond 6-8 weeks without response 5
Implement diagnostic phlebotomy reduction strategy, as mean daily phlebotomy volume in critical care is 40-80 mL and contributes to worsening anemia 1